Pfizer Could Year-End Target Hit on 2-to-1 Trial Payoff
Pfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
Knowing when to opt for index funds over stocks helps you prioritize diversification and lower maintenance while pursuing gains.
25,645 articlesPfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
Bitmine reports a fresh ETH purchase of 65,341 coins, pushing its total ETH stash to 4.661 million and fueling optimi...
Visa has won approval to join the Canton Network as its top Super Validator. The move signals deeper enterprise parti...
A sweeping market update is arriving just as tech stocks face a new mix of opportunities and risks. This arguably mos...
Oil prices pressed higher on March 26, 2026, nearing the mid-$100s per barrel. The move highlights how current price ...
Bitcoin is drawing safe-haven-like demand as geopolitical risk intensifies, with JPMorgan noting bitcoin shows resili...
Meta Platforms is pursuing a bold $9 trillion valuation by 2031 even after a blistering market setback. The plan hing...
Washington moves to outlaw noncompete agreements statewide, imposing a 2027 deadline. The sweeping policy reshapes hi...
VCR is down about 9% year-to-date, but nearly 40% of its holdings sit in Amazon and Tesla, reshaping the fund’s risk ...
Strategy reported a $12.54 billion Q1 loss driven by unrealized BTC declines, even as its software business expanded ...
Ford is retreating from broad EV production while Toyota accelerates its electrification push, setting up a decisive ...
A National Park Service interim report reveals debris from white house rubble dumped at East Potomac Golf Links tests...